Euronext N.V.

Regulatory Filings • Mar 4, 2011

CONTACT | Media: +31.20.550.4488 (Amsterdam), +32.2.509.1392 (Brussels) +351.217.900.029 (Lisbon), +44.20.7379.2789 (London) +1.212.656.2411 (New York), +33.1.49.27.11.33 (Paris)

CONTACT | Investor Relations: +1.212.656.5700 (New York) +33.1.49.27.58.60 (Paris)

NYSE Euronext Announces Trading Volumes for February 2011

Global Derivatives Averaged 8.9 Million Contracts per Day in February, Up 8% vs. Prior Year U.S Equity Options Volumes Up 33%; European Derivatives (Ex. Bclear) Up 1% European Cash Trading Volumes Up 23%, U.S. Cash Down 14%

March 4, 2011 – NYSE Euronext (NYX) today announced trading volumes for its global derivatives and cash equities exchanges for February 20111 . Global derivatives average daily volume ("ADV") of 8.9 million contracts traded per day in February 2011 increased 7.8% versus the prior year. The increase in global derivatives ADV versus prior year levels was driven primarily by a 33.4% increase in U.S. equity options ADV, partially offset by a 9.8% decrease in European derivatives ADV. Cash equities ADV in February 2011 was mixed, with European cash ADV increasing 22.9% and U.S. cash trading volumes decreasing 13.7% from February 2010 levels.

Highlights

• NYSE Euronext global derivatives ADV in February 2011 of 8.9 million contracts increased 7.8% compared to February 2010, but decreased 1.1% from January 2011 levels.
• NYSE Euronext European derivatives products ADV in February 2011 of 4.4 million contracts decreased 9.8% compared to February 2010 and decreased 5.8% from January 2011 levels. Excluding Bclear, NYSE Liffe's trade administration and clearing service for OTC products, European derivatives products ADV increased 1.5% compared to February 2010 and increased 5.6% from January 2011. Total European fixed income products ADV in February 2011 of 2.8 million contracts increased 1.3% compared to February 2010 and increased 7.3% from January 2011. Total equity products ADV of 1.5 million contracts in February 2011 decreased 26.6% compared to February 2010 and decreased 23.8% from January 2011. Total commodities products ADV of 87,000 contracts in February 2011 increased 61.3% compared to February 2010.
• NYSE Euronext U.S. equity options (NYSE Arca and NYSE Amex) ADV of 4.5 million contracts in February 2011 increased 33.4% compared to February 2010 levels and increased 4.0% from January 2011. NYSE Euronext's U.S. options exchanges accounted for 25.9% of total U.S. consolidated equity options trading in February 2011, down from 26.9% in February 2010, but up from 24.5% recorded in January 2011.
• NYSE Euronext European cash products ADV of 1.8 million transactions in February 2011 increased 22.9% compared to February 2010 and increased slightly from January 2011 levels.
• NYSE Euronext U.S. cash products (NYSE, NYSE Arca and NYSE Amex) handled ADV of 2.2 billion shares in February 2011 decreased 13.7% compared to February 2010 and decreased 5.3% compared to January 2011. NYSE Euronext's Tape A matched market share in February 2011 was 34.5%, down from 36.6% in February 2010, but up from 33.9% in January 2011.

¹ All NYSE Euronext derivatives transactions count buy and sell orders together as a single transaction. NYSE Euronext European equities transactions count each buy and sell order as separate transactions, NYSE Euronext U.S. equities transactions count buy and sell orders together as a single transaction.

• There were a total of 20 trading days in Europe and 19 trading days in the U.S. in both February 2011 and February 2010.

Derivatives Trading

European Derivatives

• NYSE Euronext European derivatives products ADV in February 2011 was 4.4 million futures and options contracts, a decrease of 9.8% from February 2010 and a decrease of 5.8% from January 2011. The 4.4 million in futures and options contracts ADV in February 2011 consisted of 3.9 million contracts executed through our full-service LIFFE CONNECT trading platform and 0.5 million contracts, or 10.7%, executed through Bclear, NYSE Liffe's trade administration and clearing service for OTC products. Excluding Bclear, European derivatives products ADV increased 1.5% compared to February 2010 and increased 5.6% from January 2011.
• Year-to-date, European derivatives products ADV of 4.6 million contracts was 8.6% below prior year levels. The 4.6 million in futures and options contracts ADV year-to-date consisted of 3.8 million contracts executed through the LIFFE CONNECT trading platform and 0.7 million contracts, or 15.8%, executed through Bclear.
• Total fixed income products ADV of 2.8 million contracts in February 2011 increased 1.3% from February 2010 and increased 7.3% from January 2011. Year-to-date, total fixed income products ADV of 2.7 million contracts was 1.6% below prior year levels.
• Total equity products (including Bclear) ADV of 1.5 million contracts in February 2011 decreased 26.6% compared to February 2010 and decreased 23.8% from January 2011. The 1.5 million contracts in equity products ADV consisted of 1.0 million contracts in individual equity products ADV and 0.5 million contracts in equity index products ADV. The 1.0 million contracts in individual equity products ADV consisted of 0.3 million in futures contracts, which represented a 61.6% decrease compared to February 2010 and 0.7 million in options contracts, which represented an 8.9% increase compared to February 2010. The average net rate per contract for individual equity futures contracts is significantly lower than other products traded on NYSE Liffe. Year-to-date, total equity products ADV of 1.8 million contracts was 19.0% below prior year levels.
• Total commodities products ADV of 87,000 contracts in February 2011 increased 61.3% compared to February 2010. Year-to-date, total commodities product ADV of 80,000 contracts was 54.5% above prior year levels.

U.S. Derivatives

• NYSE Euronext U.S. equity options (NYSE Arca and NYSE Amex) ADV of 4.5 million contracts in February 2011 increased 33.4% compared to February 2010 and increased 4.0% compared to January 2011. Year-to-date, U.S. equity options ADV of 4.4 million contracts was 16.5% above prior year levels.
• Total U.S. consolidated equity options ADV increased 38.4% to 17.5 million contracts in February 2011 compared to February 2010, but decreased 1.5% compared to January 2011. Year-to-date, U.S. consolidated equity options ADV of 17.6 million contracts was 26.5% above prior year levels.
• NYSE Euronext's U.S. options exchanges accounted for 25.9% of the total U.S. consolidated equity options trading in February 2011, down from 26.9% in February 2010, but up from 24.5% in January 2011.
• NYSE Euronext U.S. futures and futures options (NYSE Liffe U.S.) ADV in February 2011 was approximately 12,900 contracts, compared to 22,500 contracts in February 2010. Year-to-date U.S. futures and futures options ADV was 13,600 contracts, a decrease of 39.3% compared to the prior year period.

Cash Trading

European Cash

• NYSE Euronext European cash products ADV of 1.8 million transactions in February 2011 increased 22.9% compared to February 2010 and increased 0.1% compared to January 2011.
• Year-to-date, European cash products ADV of 1.8 million transactions was 25.3% above prior year levels.

U.S. Cash

• NYSE Euronext U.S. cash products handled ADV in February 2011 decreased 13.7% to 2.2 billion shares compared to February 2010 and decreased 5.3% from January 2011.
• Year-to-date, U.S. cash products handled ADV was 2.3 billion shares, down 12.9% from prior year levels.
• NYSE Euronext's Tape A matched market share in February 2011 was 34.5%, down from 36.6% in February 2010, but up from 33.9% in January 2011.

Exchange Traded Products

• NYSE Euronext U.S. matched exchange-traded products ADV (included in volumes for Tape B and Tape C) of 258 million shares in February 2011 decreased 29.0% compared to February 2010 and decreased 4.2% compared to January 2011.
• Year-to-date, NYSE Euronext U.S. matched exchange-traded products ADV of 264 million shares was 25.7% below prior year levels.

Please click here for the Monthly Transaction Activity Data Table.

About NYSE Euronext

NYSE Euronext (NYX) is a leading global operator of financial markets and provider of innovative trading technologies. The company's exchanges in Europe and the United States trade equities, futures, options, fixed-income and exchange-traded products. With approximately 8,000 listed issues (excluding European Structured Products), NYSE Euronext's equities markets – the New York Stock Exchange, NYSE Euronext, NYSE Amex, NYSE Alternext and NYSE Arca – represent one-fourth of the world's equities trading, the most liquidity of any global exchange group. NYSE Euronext also operates NYSE Liffe, one of the leading European derivatives businesses and the world's second-largest derivatives business by value of trading. The company offers comprehensive commercial technology, connectivity and market data products and services through NYSE Technologies. NYSE Euronext is in the S&P 500 index, and is the only exchange operator in the S&P 100 index and Fortune 500. For more information, please visit: http://www.nyx.com.

Cautionary Note Regarding Forward-Looking Statements

This press release August contain forward-looking statements, including forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements include, but are not limited to, statements concerning NYSE Euronext's plans, objectives, expectations and intentions and other statements that are not historical or current facts. Forward-looking statements are based on NYSE Euronext's current expectations and involve risks and uncertainties that could cause actual results to differ materially from those expressed or implied in such forward-looking statements. Factors that could cause NYSE Euronext's results to differ materially from current expectations include, but are not limited to: NYSE Euronext's ability to implement its strategic initiatives, economic, political and market conditions and fluctuations, government and industry regulation, interest rate risk and U.S. and global competition, and other factors detailed in NYSE Euronext's reference document for 2010 ("document de référence") filed with the French Autorité des Marchés Financiers (Filed on April 22, 2010 under No. D.10-0304), 2010 Annual Report on Form 10-K and other periodic reports filed with the U.S. Securities and Exchange Commission or the French Autorité des Marchés Financiers. In addition, these statements are based on a number of assumptions that are subject to change. Accordingly, actual results August be materially higher or lower than those projected. The inclusion of such projections herein should not be regarded as a representation by NYSE Euronext that the projections will prove to be correct. This press release speaks only as of this date. NYSE Euronext disclaims any duty to update the information herein.

	Average Daily Volume				Total Volume			Average Daily Volume		Total Volume
(Unaudited; contracts in thousands)	Feb-11	Feb-10	% Chg	Feb-11	Feb-10	% Chg	YTD 2011	% Chg vs. YTD 2010	YTD 2011	% Chg vs. YTD 2010
Number of Trading Days - European Markets Number of Trading Days - U.S. Markets	20 19	20 19		20 19	20 19		41 39		41 39
European Derivatives Products	4,418	4,899	-9.8%	88,355	97,984	-9.8%	4,556	-8.6%	186,796	-6.3%
of which Bclear	474		1,013 -53.2%	9,485		20,259 -53.2%	720	-30.5%	29,529	-28.8%
Total Fixed Income Products	2,813	2,777	1.3%	56,264	55,541	1.3%	2,715	-1.6%	111,324	0.9%
Short Term Interest Rate Products Medium and Long Term Interest Rate Products 1	2,649 164	2,621 156	1.1% 5.0%	52,979 3,285	52,412 3,128	1.1% 5.0%	2,581 135	-2.0% 8.6%	105,805 5,519	0.4% 11.3%
Total Equity Products 2	1,518		2,068 -26.6%	30,354		41,366 -26.6%	1,760	-19.0%	72,175	-16.9%
Individual Equity Products	1,020		1,447 -29.5%	20,392		28,937 -29.5%	1,250	-19.5%	51,256	-17.5%
Futures Options	304 716	657	789 -61.6% 8.9%	6,070 14,322	13,148	15,790 -61.6% 8.9%	532 718	-33.2% -5.0%	21,824 29,432	-31.5% -2.7%
Equity Index Products	498		621 -19.8%	9,962		12,429 -19.8%	510	-17.6%	20,920	-15.6%
of which Bclear	474		1,013 -53.2%	9,485		20,259 -53.2%	720	-30.5%	29,529	-28.8%
Individual Equity Products Futures	417 288		909 -54.1% 789 -63.5%	8,348 5,764		18,184 -54.1% 15,788 -63.5%	658 525	-28.3% -34.1%	26,964 21,511	-26.5% -32.4%
Options	129	120	7.8%	2,584	2,396	7.8%	133	10.2%	5,454	12.9%
Equity Index Products	57		104 -45.2%	1,138		2,075 -45.2%	63	-47.7%	2,565	-46.4%
Commodity Products	87	54	61.3%	1,737	1,077	61.3%	80	54.5%	3,297	58.4%
U.S. Derivatives Products
Equity Options 3
NYSE Euronext Options Contracts Total Consolidated Options Contracts	4,524 17,472	3,393 12,627	33.4% 38.4%	85,962 331,962 239,920	64,462	33.4% 38.4%	4,435 17,609	16.5% 26.5%	172,960 686,758	19.5% 29.9%
NYSE Group Share of Total	25.9%	26.9%		25.9%	26.9%		25.2%	-2.2%	25.2%	-2.2%
NYSE Liffe U.S.
Futures and Futures Options Volume	12.9		22.5 -42.6%	246		428 -42.6%	13.6	-39.3%	529.2	-37.7%
European Cash Products (trades in thousands)	1,771	1,441	22.9%	35,417	28,811	22.9%	1,770	25.3%	72,555	28.4%
Equities	1,704		1,382 23.3%	34,073		27,639 23.3%	1,701	25.8%	69,750	28.9%
Exchange-Traded Funds Structured Products	19 43	17	8.6% 36 21.6%	372 865	342	8.6% 711 21.6%	20 44	13.3% 20.7%	800 1,784	16.1% 23.7%
Bonds	5		6 -10.1%	107		119 -10.1%	5	-12.6%	221	-10.5%
U.S. Cash Products (shares in millions) 5	2,246	2,602	-13.7%	42,679 49,444		-13.7%	2,311	-12.9%	90,121	-10.6%
NYSE Listed (Tape A) Issues 4
Handled Volume 5	1,635	1,848	-11.6%	31,058	35,117	-11.6%	1,689	-10.3%	65,854	-8.0%
Matched Volume 6 Total NYSE Listed Consolidated Volume	1,542 4,463	1,728 4,720	-10.8% -5.4%	29,294 84,806	32,837 89,688	-10.8% -5.4%	1,594 4,661	-8.8% -5.5%	62,166 181,791	-6.4% -3.0%
Share of Total Consolidated Volume
Handled Volume 5	36.6%	39.2%	-2.6%	36.6%	39.2%	-2.6%	36.2%	-2.0%	36.2%	-2.0%
Matched Volume 6	34.5%	36.6%	-2.1%	34.5%	36.6%	-2.1%	34.2%	-1.2%	34.2%	-1.2%
NYSE Arca & Amex (Tape B) Listed Issues
Handled Volume 5	317	421	-24.6%	6,022	7,991	-24.6%	325	-21.9%	12,670	-19.9%
Matched Volume 6 Total NYSE Arca & Amex Listed Consolidated Volume	284 1,267	373 1,612	-23.9% -21.4%	5,396 24,067	7,089 30,635	-23.9% -21.4%	291 1,277	-20.6% -20.0%	11,364 49,820	-18.5% -17.9%
Share of Total Consolidated Volume
Handled Volume 5	25.0%	26.1%	-1.1%	25.0%	26.1%	-1.1%	25.4%	-0.7%	25.4%	-0.7%
Matched Volume 6	22.4%	23.1%	-0.7%	22.4%	23.1%	-0.7%	22.8%	-0.2%	22.8%	-0.2%
Nasdaq Listed (Tape C) Issues
Handled Volume 5 Matched Volume 6	295	334	-11.6%	5,600	6,337	-11.6%	297	-15.6%	11,597	-13.4%
Total Nasdaq Listed Consolidated Volume	252 2,096	278 2,253	-9.4% -7.0%	4,783 39,815	5,281 42,813	-9.4% -7.0%	253 2,069	-12.7% -11.9%	9,881 80,697	-10.4% -9.6%
Share of Total Consolidated Volume
Handled Volume 5	14.1%	14.8%	-0.7%	14.1%	14.8%	-0.7%	14.4%	-0.6%	14.4%	-0.6%
Matched Volume 6	12.0%	12.3%	-0.3%	12.0%	12.3%	-0.3%	12.2%	-0.2%	12.2%	-0.2%
Exchange-Traded Funds 5,7
Handled Volume 5 Matched Volume 6	289	409	-29.5%	5,484	7,777	-29.5%	294	-26.7%	11,480	-24.8%
Total ETF Consolidated Volume	258 1,171	364 1,611	-29.0% -27.3%	4,911 22,251	6,916 30,607	-29.0% -27.3%	264 1,173	-25.7% -25.7%	10,307 45,757	-23.7% -23.8%
Share of Total Consolidated Volume
Handled Volume 5	24.6%	25.4%	-0.8%	24.6%	25.4%	-0.8%	25.1%	-0.3%	25.1%	-0.3%
Matched Volume 6	22.1%	22.6%	-0.5%	22.1%	22.6%	-0.5%	22.5%	0.0%	22.5%	0.0%

7 Data included in previously identified categories.

Source: NYSE Euronext, Options Clearing Corporation and Consolidated Tape as reported for equity securities.

All trading activity is single-counted, except European cash trading which is double counted to include both buys and sells.

5 Represents the total number of shares of equity securities and ETFs internally matched on the NYSE Group's exchanges or routed to and executed at an external market center. NYSE Arca routing includes odd-lots.

4 Includes all volume executed in NYSE Group crossing sessions.

6 Represents the total number of shares of equity securities and ETFs executed on the NYSE Group's exchanges.

1 Data includes currency products.

2 Includes Bclear trading Includes all trading activities for Bclear, NYSE Liffe's clearing service for wholesale derivatives.

3 Includes trading in U.S. equity options contracts, not equity-index options.

NYSE Euronext Monthly Volume Summary